• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ VIVITY EXTENDED VISION IOL; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ VIVITY EXTENDED VISION IOL; INTRAOCULAR LENS Back to Search Results
Model Number DFT015
Medical Device Problem Codes Break (1069); Device Dislodged or Dislocated (2923); Insufficient Device Problem Information (3190)
Health Effect - Clinical Codes Blurred Vision (2137); Capsular Bag Tear (2639); Insufficient Information (4580)
Date of Event 05/29/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A sample device was not returned for analysis.Complaint history and product history record could not be reviewed because the reporting facility did not provide a valid lot number or any identification traceable to the manufacturing documentation.Root cause has not been identified.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A nurse reported that, following intraocular lens implant procedure, the iol was explanted due to medical reasons.
 
Event or Problem Description
Additional information was received from the hcp indicating that the patient experienced an iol drop caused or contributed by a posterior capsule gap.The patient also experienced reduced visual acuity.The iol was exchanged for another lens model one week following the initial implant procedure.It was reported the patient was hospitalized as a result of the event.The patient¿s issues have resolved following the secondary procedure.
 
Additional Manufacturer Narrative
The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
Additional information was received from the hcp that during iol implantation, a small corner of haptic broke off which eventually caused the posterior capsule rupture.
 
Additional Manufacturer Narrative
The product was not returned.Product history records were reviewed and documentation indicated the product met release criteria.Information indicated a company handpiece was used, however it stated a company cartridge was not used.A non- company viscoelastic was indicated.The reported damaged haptic may be related to a failure to follow the instructions for use (ifu).Information indicated a company handpiece was used, however it stated a monarch cartridge was not used.The ifu instructs that a company qualified delivery system and viscoelastic combination should be used.The use of an unqualified combination may cause damage to the lens and potential complications during the implantation process.Company foldable iols are qualified for use with a company qualified delivery system (handpiece and cartridge) and ophthalmic viscosurgical device (ovd) combination.Original information stated the lens was replaced due to a medical issue.Further information was provided that the company lens was replaced with an anterior chamber iol due to an iol dislocation related to a posterior capsule gap.Upon further request for information it was indicated "small corner of haptic broke off during implantation which eventually caused the posterior capsule rupture".There have been no other complaints reported in the lot number.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACRYSOF IQ VIVITY EXTENDED VISION IOL
Common Device Name
INTRAOCULAR LENS
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key14831434
Report Number1119421-2022-01389
Device Sequence Number19424929
Product Code POE
UDI-Device Identifier00380652421218
UDI-Public00380652421218
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
P930014
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Device Explanted Year2022
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Nurse
Type of Report Initial,Followup,Followup
Report Date (Section B) 09/13/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date07/28/2026
Device Model NumberDFT015
Device Lot Number15240271
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 06/02/2022
Supplement Date Received by Manufacturer06/29/2022
08/15/2022
Initial Report FDA Received Date06/27/2022
Supplement Report FDA Received Date07/28/2022
09/13/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured07/30/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
MONARCH INJECTOR, UNSPECIFIED.; NON COMPANY CARTRIDGE.; VERISYS.; Z-CELCOAT.
Outcome Attributed to Adverse Event Other; Hospitalization; Required Intervention;
Patient Age67 YR
Patient SexFemale
-
-